Amedisys: Q3 Earnings Insights - Amedisys (NASDAQ:AMED)

Amedisys AMED reported its Q3 earnings results on Wednesday, October 26, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Amedisys missed estimated earnings by 5.74%, reporting an EPS of $1.15 versus an estimate of $1.22.

Revenue was up $4.50 million from the same period last year.

Last quarter the company beat on EPS by $0.24 which was followed by a 4.81% drop in the share price the next day.

Here's a look at Amedisys's past performance:

Quarter	Q2 2022	Q1 2022	Q4 2021	Q3 2021
EPS Estimate	1.23	1.12	1.18	1.36
EPS Actual	1.47	1.23	1.18	1.53
Revenue Estimate	583.12M	558.84M	555.20M	568.37M
Revenue Actual	557.89M	545.26M	559.32M	553.49M

To track all earnings releases for Amedisys visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.